Latest filing published 25 Aug 2022 for Love Pharma Inc. (formerly Glenbriar Technologies Inc.), €27k.
All filings by Zachary Thomas Stadnyk on record concern Love Pharma Inc. (formerly Glenbriar Technologies Inc.). Over a trading history stretching from 8 June 2022 to 24 August 2022, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 25 August 2022, reports a transaction of €27k in Love Pharma Inc. (formerly Glenbriar Technologies Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations